Repligen Corp. (RGEN)
125.36
+3.05
(+2.49%)
USD |
NASDAQ |
Jun 08, 15:50
Repligen Total Liabilities (Quarterly) : 825.31M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Bio-Techne Corp. | 465.30M |
| BioLife Solutions, Inc. | 28.68M |
| MindWalk Holdings Corp. | 6.002M |
| Maravai Lifesciences Holdings, Inc. | 344.13M |
| MaxCyte, Inc. | 26.59M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.931B |
| Shareholders Equity (Quarterly) | 2.105B |
| Debt to Equity Ratio | 0.3266 |
| Current Ratio | 9.202 |
| Net Debt Paydown Yield | -0.00% |